Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ruben Karapetian"'
Autor:
Ola A Elgamal, James R Lerma, Allison Mullaney, Emily Stahl, Blaise Stearns, Andrew Orry, Polo Chun-Hung Lam, Ruben Abagyan, Alexei Pushechnikov, Nikolay Savchuk, Volodymyr Kysil, Hovhannes Gukasyan, Iain Dukes, Oleg Mitkin, Ruben Karapetian, Alexei Riakhovskii, Elena Bulanova, Vladislav Parchinsky, Alexandre Ivachtchenko, Sharyn Baker, Erin Hertlein, John C. Byrd
Publikováno v:
Blood. 140:3352-3353
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3a88862741dae20c656d2b888fdbd69d
https://doi.org/10.1182/blood-2022-165675
https://doi.org/10.1182/blood-2022-165675
Autor:
Andrey Ivashchenko, Valeria Azarova, Alina Egorova, Ruben Karapetian, Dmitry Kravchenko, Natalia Krivonos, Vladimir Loginov, Stanislav Poyarkov, Elena Merkulova, Olga Rosinkova, Nikolay Savchuk, Mikhail Topr, Elena Simakina, Elena Yakubova, Alexandre Ivachtchenko
Objectives. COVID-19 is a contagious multisystem inflammatory disease caused by a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We have studied the efficacy of Aprotinin (nonspecific serine proteases inhibitor) and Avifavir or Hydrox
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1876dc8f4692fee52b4373f46ce3dc55
https://doi.org/10.21055/preprints-3111905
https://doi.org/10.21055/preprints-3111905
Autor:
Andrey Ivashchenko, Andrey Svistunov, Tatiana Khorobryh, Vladimir Loginov, Ruben Karapetian, Natalia Mishchenko, Stanislav Poyarkov, Michael Topr, Maksim Volgin, Elena Yakubova, Alexandre Ivachtchenko
Aprotinin showed high efficacy and safety in a prospective study of combination therapy for hospitalized patients with moderate to severe COVID-19 pneumonia.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::892a056b9452b5dbb04ff12471c83cc9
https://doi.org/10.21055/preprints-3111821
https://doi.org/10.21055/preprints-3111821
Autor:
Andrey Ivashchenko, Andrey Svistunov, Tatiana Khorobryh, Vladimir Loginov, Ruben Karapetian, Natalia Mishchenko, Stanislav Poyarkov, Maxim Volgin, Elena Yakubova, Michael Topr, Oleg Pyankov, Anastasia Magerramova, Alexey Tomilov, Alexandre Ivashchenko
The efficacy of Aprotinin as prophylactic treatment of Covid-19 was studied in the hamster model of SARS-CoV-2 and in the health care personnel working with Covid-19 patients in hospital. High efficacy of Aprotinin in pre- and post-exposure prophylax
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1ee0c07d5698ec5a1d5e14553861b8f9
https://doi.org/10.21055/preprints-3111813
https://doi.org/10.21055/preprints-3111813